Secretory phospholipase A2-IID is an effector molecule of CD4 + CD25 + regulatory T cells
Name:
Von Allmen et al.pdf
Size:
617.2Kb
Format:
PDF
Description:
free copy from BioMed Central's ...
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
von Allmen, Caroline E.Schmitz, Nicole
Bauer, Monika
Hinton, Heather J.
Kurrer, Michael O.
Buser, Regula B.
Gwerder, Myriam
Muntwiler, Simone
Sparwasser, Tim
Beerli, Roger R.
Bachmann, Martin F.
Issue Date
2009-07-14
Metadata
Show full item recordCitation
Secretory phospholipase A2-IID is an effector molecule of CD4 + CD25 + regulatory T cells 2009, 106 (28):11673 Proceedings of the National Academy of SciencesAffiliation
TWINCORE, Centre for Experimental and Clinical Infection Research GmbH, Feodor-Lynen-Str. 3-7, 30625 Hannover, Germany.PubMed ID
19564598Additional Links
http://www.pnas.org/lookup/doi/10.1073/pnas.0812569106Type
ArticleISSN
1091-6490ae974a485f413a2113503eed53cd6c53
10.1073/pnas.0812569106
Scopus Count
The following license files are associated with this item:
Related articles
- RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
- Authors: Totsuka T, Kanai T, Nemoto Y, Tomita T, Okamoto R, Tsuchiya K, Nakamura T, Sakamoto N, Akiba H, Okumura K, Yagita H, Watanabe M
- Issue date: 2009 May 15
- Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
- Authors: Luan YY, Yao YM, Zhang L, Dong N, Zhang QH, Yu Y, Sheng ZY
- Issue date: 2011 Oct
- Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells.
- Authors: Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C, Protschka M, Galle PR, Neurath MF, Blessing M
- Issue date: 2004 Dec 1
- Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3(+) Tregs in vitro.
- Authors: DeOca KB, Moorman CD, Garcia BL, Mannie MD
- Issue date: 2020
- Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
- Authors: Li X, Acuff NV, Peeks AR, Kirkland R, Wyatt KD, Nagy T, Watford WT
- Issue date: 2016 Aug 5